A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL
A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL
Recruiting · NCT07350850 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL | primary central nervous system lymphoma | Recruiting | Phase 2 | 2026-06-02 | NCT07350850 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China-Japan Union Hospital of Jilin University | Changchun | China | 17 |
| Shanxi Provincial People's Hospital | Taiyuan | China | 6 |
| The First Affiliated Hospital of Fujian Medical University | Xiamen | China | 1 |
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 28 |